108 related articles for article (PubMed ID: 7987495)
1. High-performance liquid chromatographic assay of the magnetic resonance imaging contrast agent gadobenate in plasma, urine and bile.
Lorusso V; Poggesi I; Arbughi T; Dal Fiume D; Tirone P
J Chromatogr B Biomed Appl; 1994 Jun; 656(2):415-22. PubMed ID: 7987495
[TBL] [Abstract][Full Text] [Related]
2. High-performance liquid chromatographic determination of the magnetic resonance imaging contrast agent gadobenate ion in plasma, urine, faeces, bile and tissues.
Arbughi T; Bertani F; Celeste R; Grotti A; Sillari S; Tirone P
J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(2):415-26. PubMed ID: 9746258
[TBL] [Abstract][Full Text] [Related]
3. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) as contrast agent for magnetic resonance imaging of the liver: mechanistic studies in animals.
de Haën C; La Ferla R; Maggioni F
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S169-79. PubMed ID: 10608413
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tissue distribution in animals of gadobenate ion, the magnetic resonance imaging contrast enhancing component of gadobenate dimeglumine 0.5 M solution for injection (MultiHance).
Lorusso V; Arbughi T; Tirone P; de Haën C
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S181-94. PubMed ID: 10608414
[TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic determination of the magnetic resonance imaging contrast agent Gadocoletate ion in human plasma, urine and faeces.
Setti I; Celeste R; Mariani G; Dal Fiume D; Morisetti A; Lorusso V
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 835(1-2):1-15. PubMed ID: 16574506
[TBL] [Abstract][Full Text] [Related]
6. Hepatic transport of the magnetic resonance imaging contrast agent gadobenate dimeglumine in the rat.
de Haën C; Lorusso V; Luzzani F; Tirone P
Acad Radiol; 1995 Mar; 2(3):232-8. PubMed ID: 9419554
[TBL] [Abstract][Full Text] [Related]
7. How transfer rates generate Gd-BOPTA concentrations in rat liver compartments: implications for clinical liver imaging with hepatobiliary contrast agents.
Pastor CM
Contrast Media Mol Imaging; 2016 Jul; 11(4):291-8. PubMed ID: 27060676
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and safety of gadobenate dimeglumine (multihance) in subjects with impaired liver function.
Davies BE; Kirchin MA; Bensel K; Lorusso V; Davies A; Parker JR; Lafrance ND
Invest Radiol; 2002 May; 37(5):299-308. PubMed ID: 11979156
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation.
Pastor CM; Planchamp C; Pochon S; Lorusso V; Montet X; Mayer J; Terrier F; Vallee JP
Radiology; 2003 Oct; 229(1):119-25. PubMed ID: 12944603
[TBL] [Abstract][Full Text] [Related]
10. Gadobenate dimeglumine (Gd-DTPA) vs gadopentetate dimeglumine (Gd-BOPTA) for contrast-enhanced magnetic resonance angiography (MRA): improvement in intravascular signal intensity and contrast to noise ratio.
Pediconi F; Fraioli F; Catalano C; Napoli A; Danti M; Francone M; Venditti F; Nardis P; Passariello R
Radiol Med; 2003; 106(1-2):87-93. PubMed ID: 12951555
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention.
Kuhn MJ; Picozzi P; Maldjian JA; Schmalfuss IM; Maravilla KR; Bowen BC; Wippold FJ; Runge VM; Knopp MV; Wolansky LJ; Gustafsson L; Essig M; Anzalone N
J Neurosurg; 2007 Apr; 106(4):557-66. PubMed ID: 17432704
[TBL] [Abstract][Full Text] [Related]
12. Compensatory biliary and urinary excretion of gadobenate ion after administration of gadobenate dimeglumine (MultiHance(®)) in cases of impaired hepatic or renal function: a mechanism that may aid in the prevention of nephrogenic systemic fibrosis?
Kirchin MA; Lorusso V; Pirovano G
Br J Radiol; 2015 Apr; 88(1048):20140526. PubMed ID: 25651409
[TBL] [Abstract][Full Text] [Related]
13. Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intra-individual crossover comparison.
Schneider G; Maas R; Schultze Kool L; Rummeny E; Gehl HB; Lodemann KP; Kirchin MA
Invest Radiol; 2003 Feb; 38(2):85-94. PubMed ID: 12544071
[TBL] [Abstract][Full Text] [Related]
14. Quantification and excretion kinetics of a magnetic resonance imaging contrast agent by capillary electrophoresis-mass spectrometry.
Künnemeyer J; Terborg L; Nowak S; Brauckmann C; Telgmann L; Albert A; Tokmak F; Krämer BK; Günsel A; Wiesmüller GA; Karst U
Electrophoresis; 2009 May; 30(10):1766-73. PubMed ID: 19441033
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases].
Wang QJ; Wang Y; Xu X; Xiao H; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693
[TBL] [Abstract][Full Text] [Related]
16. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
[TBL] [Abstract][Full Text] [Related]
17. Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.
Colosimo C; Demaerel P; Tortori-Donati P; Christophe C; Van Buchem M; Högström B; Pirovano G; Shen N; Kirchin MA; Spinazzi A
Pediatr Radiol; 2005 May; 35(5):501-10. PubMed ID: 15678342
[TBL] [Abstract][Full Text] [Related]
18. Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for magnetic resonance imaging of liver tumors.
Kuwatsuru R; Kadoya M; Ohtomo K; Tanimoto A; Hirohashi S; Murakami T; Tanaka Y; Yoshikawa K; Katayama H
Invest Radiol; 2001 Nov; 36(11):632-41. PubMed ID: 11606840
[TBL] [Abstract][Full Text] [Related]
19. Liver Perfusion Modifies Gd-DTPA and Gd-BOPTA Hepatocyte Concentrations Through Transfer Clearances Across Sinusoidal Membranes.
Daire JL; Leporq B; Vilgrain V; Van Beers BE; Schmidt S; Pastor CM
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):657-667. PubMed ID: 27778300
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings.
Grazioli L; Morana G; Caudana R; Benetti A; Portolani N; Talamini G; Colombari R; Pirovano G; Kirchin MA; Spinazzi A
Invest Radiol; 2000 Jan; 35(1):25-34. PubMed ID: 10639033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
